0000899243-23-009172.txt : 20230320
0000899243-23-009172.hdr.sgml : 20230320
20230320202225
ACCESSION NUMBER: 0000899243-23-009172
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230316
FILED AS OF DATE: 20230320
DATE AS OF CHANGE: 20230320
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Firestone Karen
CENTRAL INDEX KEY: 0001969821
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41199
FILM NUMBER: 23747635
MAIL ADDRESS:
STREET 1: C/O AMYLYX PHARMACEUTICALS, INC.
STREET 2: 43 THORNDIKE ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Amylyx Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001658551
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 464600503
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 43 THORNDIKE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
BUSINESS PHONE: 617-683-0917
MAIL ADDRESS:
STREET 1: 43 THORNDIKE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-03-16
0
0001658551
Amylyx Pharmaceuticals, Inc.
AMLX
0001969821
Firestone Karen
C/O AMYLYX PHARMACEUTICALS, INC.
43 THORNDIKE STREET
CAMBRIDGE
MA
02141
1
0
0
0
0
Common Stock
2023-03-16
4
P
0
1000
31.99
A
1000
D
Stock Option (Right to Buy)
32.08
2023-03-16
4
A
0
27403
0.00
A
2033-03-16
Common Stock
27403
27403
D
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.96 to $32.00. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request
One-third of the shares subject to the option shall vest on the first anniversary of the date of grant, and the remaining two-thirds will vest in equal monthly installments over two years, provided, however, that all vesting shall cease if the director resigns from the Board or otherwise ceases to serve as a director of the Issuer.
/s/ Joshua B. Cohen, as Attorney in Fact
2023-03-20